glp 1 drugs brand names How GLP-1 medications are transforming diabetes and weight loss treatment GLP-1 Medications for Weight Loss:

Impact on Patients and Access The consequences for patients are not theoretical

doi: 10.1056/NEJMoa1812389 58 PerkovicVJardineMJNealBBompointSHeerspinkHJLCharytanDMet al

By indication type, the type 2 diabetes (T2D) segment dominated the market with a 58% share in 2025

For individuals with NAFLD or disproportionate visceral adiposity that persists despite GLP-1-mediated weight loss, adding tesamorelin targets the remaining visceral fat through GH-stimulated lipolysis

They also interact with the brain's appetite centers, suppressing hunger and influencing hormones that regulate appetite

In the literature, I dont think that there is a strong association as of yet, but clinically we are definitely seeing a lot of patients in practice either with telogen effluvium or androgenetic alopecia, which we do believe is somehow being caused by the use of these medications, Nusbaum said